Heart

The Trendlines Group’s portfolio company MediValve has received CE Mark clearance for its acWire guidewire, to facilitate the accurate placement and alignment of medical devices in the cardiovascular system during diagnostic and interventional procedures.

MediValve received this approval following review of a technical file submission by the Institute for Testing and Certification.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The acWire guidewire is a single-use, fully disposable device utilising shape-memory alloy technology intended to enable identification of cardiovascular structures during standard flouroscopic imaging.

It is designed for use with all currently available trans-catheter aortic-valve implantation (TAVI) systems.

Without changing the standard TAVI implant procedure, acWire provides the cardiologist with a continuous, clear, and precise landmark where to implant the prosthetic valve.

According to the company, the device relies on latest standard methods and techniques that are used by interventional cardiologists to access the cardiovascular system.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"acWire has been designed to shorten procedure time, reduce usage of radiation and contrast media, and improve clinical outcomes."

Once directed to a selected cardiovascular location, acWire is deformable under fluoroscopy to identify a desired specific anatomical landmark for subsequent therapeutic treatment by the clinician.

acWire has been designed to shorten procedure time, reduce usage of radiation and contrast media, and improve clinical outcomes.

MediValve CEO Assaf Klein said: "We anticipate significant clinical interest for this innovative technology. This is the first in a series of regulatory applications while we continue our development of several additional acWire products."

MediValve has already filed 510(k) application with the US Food and Drug Administration for the acWire system.

Image: The MediValve acWire Guidewire is a single-use, fully disposable medical device. Photo: courtesy of Yaddah.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact